IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
119 hedge funds and large institutions have $391M invested in IVERIC bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 11 closing their positions.
400% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 11
267% more funds holding in top 10
Funds holding in top 10: 3 → 11 (+8)
246% more capital invested
Capital invested by funds: $113M → $391M (+$278M)
65% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 20
59% more funds holding
Funds holding: 75 → 119 (+44)
16% more call options, than puts
Call options by funds: $1.27M | Put options by funds: $1.09M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$29.6M |
| 2 |
RI
RTW Investments
New York
|
+$27.5M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
+$24.9M |
| 4 |
DM
Deerfield Management
New York
|
+$14.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$8.9M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.34M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$2.64M |
| 4 |
Millennium Management
New York
|
-$1.77M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.38M |
ISEE Hedge Fund Activity: Q2 2020 in Review
119 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2020, worth a combined $391M — up 246% from $113M a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new ISEE positions and 11 closed out — a net gain of 44 holders — while 33 added to existing stakes and 20 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $29.6M. The largest seller was VR Adviser, exiting entirely with an estimated $8.9M sold.
- 119 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2020, up from 75 in Q1 2020.
- Funds reported $391M of IVERIC bio, Inc. Common Stock stock for Q2 2020, up 246% quarter-over-quarter.
- 55 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2020 and 11 closed out, a net change of +44 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q2 2020 was Avoro Capital Advisors, an estimated $29.6M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q2 2020 was VR Adviser, an estimated $8.9M sold.
Based on aggregated 13F filings for Q2 2020.